N. J. Abbott, L. Ronnback, and E. Hansson, Astrocyte-endothelial interactions at the blood-brain barrier, Nat. Rev. Neurosci, vol.7, pp.41-53, 2006.
DOI : 10.1038/nrn1824

C. Adamson, O. O. Kanu, A. I. Mehta, C. Di, N. Lin et al., Glioblastoma multiforme: a review of where we have been and where we are going, Expert Opin. Investig. Drugs, vol.18, pp.1061-1083, 2009.
DOI : 10.1517/13543780903052764

A. Aguzzi, B. A. Barres, and M. L. Bennett, Microglia: scapegoat, saboteur, or something else?, Science, vol.339, pp.156-161, 2013.
DOI : 10.1126/science.1227901
URL : http://europepmc.org/articles/pmc4431634?pdf=render

E. Allard, N. T. Huynh, A. Vessieres, P. Pigeon, G. Jaouen et al., Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, Int. J. Pharm, vol.379, pp.317-323, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01230396

E. Allard, C. Passirani, and J. P. Benoit, Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, pp.2302-2318, 2009.

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, J. Control. Release, vol.130, pp.146-153, 2008.
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557

T. M. Allen, Long-circulating (sterically stabilized) liposomes for targeted drug delivery, Trends Pharmacol. Sci, vol.15, pp.215-220, 1994.
DOI : 10.1016/0165-6147(94)90314-x

T. M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-young, Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta, vol.1066, pp.29-36, 1991.

R. Alyautdin, I. Khalin, M. I. Nafeeza, M. H. Haron, and D. Kuznetsov, Nanoscale drug delivery systems and the blood-brain barrier, International journal of nanomedicine, vol.9, pp.795-811, 2014.

R. N. Alyautdin, V. E. Petrov, K. Langer, A. Berthold, D. A. Kharkevich et al., Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles, Pharm. Res, vol.14, pp.325-328, 1997.

A. Ambruosi, S. Gelperina, A. Khalansky, S. Tanski, A. Theisen et al., Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly (butyl cyanoacrylate) nanoparticles in a rat glioma model, J. Microencapsul, vol.23, pp.582-592, 2006.

A. Ambruosi, A. S. Khalansky, H. Yamamoto, S. E. Gelperina, D. J. Begley et al., Biodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing rats, J. Drug Target, vol.14, pp.97-105, 2006.

S. Ananda, A. K. Nowak, L. Cher, A. Dowling, C. Brown et al., Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy, J. Clin. Neurosci, vol.18, pp.1444-1448, 2011.

K. Andrieux, E. Garcia-garcia, H. R. Kim, and P. Couvreur, Colloidal carriers: a promising way to treat central nervous system diseases, Journal of Nanoneuroscience, vol.1, pp.17-34, 2009.

N. Anton, J. P. Benoit, and P. Saulnier, Design and production of nanoparticles formulated from nano-emulsion templates-a review, J. Control. Release, vol.128, pp.185-199, 2008.

N. Anton, P. Saulnier, C. Gaillard, E. Porcher, S. Vrignaud et al., Aqueous-core lipid nanocapsules for encapsulating fragile hydrophilic and/or lipophilic molecules, Langmuir, vol.25, pp.11413-11419, 2009.

A. Asokan and M. J. Cho, Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids, Biochim. Biophys. Acta, vol.1611, pp.151-160, 2003.

P. Bailey, H. ;. Cushing, N. Noiret, F. Hindré, B. Denizot et al., A classification of the tumours of the glioma group on a histogenetic basis with a correlated study of prognosis, p.99, 1926.

/. Tc,

, Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, Eur. J. Nucl. Med. Mol. Imaging, vol.33, pp.602-607

A. D. Bangham and R. W. Horne, Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope, J. Mol. Bio, vol.8, pp.660-668, 1964.

A. D. Bangham, M. M. Standish, and J. C. Watkins, Diffusion of univalent ions across the lamellae of swollen phospholipids, J. Mol. Biol, vol.13, pp.238-252, 1965.

A. D. Bangham, M. M. Standish, and G. Weissmann, The action of steroids and streptolysin S on the permeability of phospholipid structures to cations, J. Mol. Biol, vol.13, pp.253-259, 1965.

A. Beduneau, F. Hindre, A. Clavreul, J. C. Leroux, P. Saulnier et al., Brain targeting using novel lipid nanovectors, J. Control. Release, vol.126, pp.44-49, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00258097

D. J. Begley, Delivery of therapeutic agents to the central nervous system: the problems and the possibilities, Pharmacol. Ther, vol.104, pp.29-45, 2004.

C. P. Beier, C. Schmid, T. Gorlia, C. Kleinletzenberger, D. Beier et al., RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study, BMC Cancer, vol.9, p.308, 2009.

Z. Belhadj, M. Ying, X. Cao, X. Hu, C. Zhan et al., Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery, J. Control. Release, vol.255, pp.132-141, 2017.

A. Bergamo and G. Sava, Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs, Dalton Trans, vol.40, pp.7817-7823, 2011.

J. Bernacki, A. Dobrowolska, K. Nierwinska, and A. Malecki, Physiology and pharmacological role of the blood-brain barrier, Pharmacol. Rep, vol.60, pp.600-622, 2008.

G. Bhabra, A. Sood, B. Fisher, L. Cartwright, M. Saunders et al., Nanoparticles can cause DNA damage across a cellular barrier, Nature Nanotechnology, vol.4, pp.876-883, 2009.

S. Bhaskar, F. Tian, T. Stoeger, W. Kreyling, J. M. De-la-fuente et al., Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging, Part. Fibre Toxicol, vol.7, p.3, 2010.

Y. Bian, M. Ye, C. Wang, K. Cheng, C. Song et al., Global screening of CK2 kinase substrates by an integrated phosphoproteomics workflow, 2013.

J. Bianco, C. Bastiancich, A. Jankovski, A. Des-rieux, V. Preat et al., On glioblastoma and the search for a cure: where do we stand?, Cell. Mol. Life Sci, pp.2451-2466, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02076749

D. F. Birt, D. Mitchell, B. Gold, P. Pour, and H. C. Pinch, Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid, Anticancer Res, vol.17, pp.85-91, 1997.

D. F. Birt, B. Walker, M. G. Tibbels, and E. Bresnick, Anti-mutagenesis and antipromotion by apigenin, robinetin and indole-3-carbinol, Carcinogenesis, vol.7, pp.959-963, 1986.

R. H. Bobo, D. W. Laske, A. Akbasak, P. F. Morrison, R. L. Dedrick et al., Convection-enhanced delivery of macromolecules in the brain, Proceedings of the National Academy of Sciences of the United States of America, vol.91, pp.2076-2080, 1994.

M. I. Borges-walmsley, K. S. Mckeegan, and A. R. Walmsley, Structure and function of efflux pumps that confer resistance to drugs, Biochem. J, vol.376, pp.313-338, 2003.

S. S. Braga and A. M. Silva, A New Age for Iron: Antitumoral Ferrocenes, Organometallics, vol.32, pp.5626-5639, 2013.

M. Bragagni, N. Mennini, C. Ghelardini, and P. Mura, Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting, J Pharm. Pharm. Sci, vol.15, pp.184-196, 2012.

E. C. Brantley, L. B. Nabors, G. Y. Gillespie, Y. H. Choi, C. A. Palmer et al., Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression, Clin. Cancer Res, vol.14, pp.4694-4704, 2008.

H. Brem, S. Piantadosi, P. C. Burger, M. Walker, R. Selker et al., Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group, Lancet, vol.345, pp.1008-1012, 1995.

I. Brigger, J. Morizet, G. Aubert, H. Chacun, M. J. Terrier-lacombe et al., Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting, J. Pharmacol. Exp. Ther, vol.303, pp.928-936, 2002.

C. Brignole, G. Pagnan, D. Marimpietri, E. Cosimo, T. M. Allen et al., Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment, Cancer Lett, vol.197, pp.231-235, 2003.

A. M. Butt, H. C. Jones, and N. J. Abbott, Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study, J. Physiol, vol.429, pp.47-62, 1990.

P. Calvo, B. Gouritin, H. Chacun, D. Desmaële, J. D'angelo et al., Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery, Pharm. Res, vol.18, pp.1157-1166, 2001.

H. I. Chang and M. K. Yeh, Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy, International journal of nanomedicine, vol.7, pp.49-60, 2012.

G. Charest, L. Sanche, D. Fortin, D. Mathieu, and B. Paquette, Glioblastoma treatment: bypassing the toxicity of platinum compounds by using liposomal formulation and increasing treatment efficiency with concomitant radiotherapy, Int. J. Radiat. Oncol. Biol. Phys, vol.84, pp.244-249, 2012.

H. Chen, L. Tang, Y. Qin, Y. Yin, J. Tang et al., Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery, Eur. J. Pharm. Sci, vol.40, pp.94-102, 2010.

Y. Chen and L. Liu, Modern methods for delivery of drugs across the blood-brain barrier, Advanced drug delivery reviews, vol.64, pp.640-665, 2012.

Z. S. Chen, K. Lee, S. Walther, R. B. Raftogianis, M. Kuwano et al., Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system, Cancer Res, vol.62, pp.3144-3150, 2002.

O. L. Chinot, W. Wick, W. Mason, R. Henriksson, F. Saran et al., Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma, N. Engl. J. Med, vol.370, pp.709-722, 2014.

E. F. Choo, D. Kurnik, M. Muszkat, T. Ohkubo, S. D. Shay et al., Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier, J. Pharmacol. Exp. Ther, vol.317, pp.1012-1018, 2006.

S. L. Chua, M. A. Rosenthal, S. S. Wong, D. M. Ashley, A. M. Woods et al., Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme, Neuro Oncol, vol.6, pp.38-43, 2004.

A. Citta, A. Folda, A. Bindoli, P. Pigeon, S. Top et al., Evidence for targeting thioredoxin reductases with ferrocenyl quinone methides. A possible molecular basis for the antiproliferative effect of hydroxyferrocifens on cancer cells, J. Med. Chem, vol.57, pp.8849-8859, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01230376

M. J. Coloma, H. J. Lee, A. Kurihara, E. M. Landaw, R. J. Boado et al., Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor, Pharm. Res, vol.17, pp.266-274, 2000.

J. Correale and A. Villa, Cellular elements of the blood-brain barrier, Neurochem. Res, vol.34, pp.2067-2077, 2009.

P. Couvreur, Polyalkylcyanoacrylates as colloidal drug carriers, Crit. Rev. Ther. Drug Carrier Syst, vol.5, pp.1-20, 1987.

P. Couvreur, C. Dubernet, and F. Puisieux, Controlled drug delivery with nanoparticles: current possibilities and future trends, Eur. J. Pharm. Biopharm, vol.41, pp.2-13, 1995.

R. Daneman and M. Rescigno, The gut immune barrier and the blood-brain barrier: are they so different?, Immunity, vol.31, pp.722-735, 2009.

A. Das, N. L. Banik, and S. K. Ray, Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes, Cancer, vol.116, pp.164-176, 2010.

A. G. De-boer and P. J. Gaillard, Drug targeting to the brain, Annu. Rev. Pharmacol. Toxicol, vol.47, pp.323-355, 2007.

N. Denora, A. Trapani, V. Laquintana, A. Lopedota, and G. Trapani, Recent advances in medicinal chemistry and pharmaceutical technology-strategies for drug delivery to the brain, Curr. Top. Med. Chem, vol.9, pp.182-196, 2009.

, ACNU administration in newly diagnosed primary glioblastomas, Anticancer Res, vol.26, pp.553-558

M. L. Immordino, F. Dosio, and L. Cattel, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, International journal of nanomedicine, vol.1, pp.297-315, 2006.

G. Jaouen and S. Top, The ferrocifen family as potent and selective antitumor compounds: mechanisms of action, pp.563-580, 2014.

G. Jaouen, S. Top, A. Vessières, P. Pigeon, G. Leclercq et al., First antioestrogen in the cyclopentadienyl rhenium tricarbonyl series. Synthesis and study of antiproliferative effects, Chemical Communications, pp.383-384, 2001.
URL : https://hal.archives-ouvertes.fr/hal-01230409

G. Jaouen, A. Vessieres, and S. Top, Ferrocifen type anti cancer drugs, Chem. Soc. Rev, vol.44, pp.8802-8817, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01221048

Y. Jeong, S. Jin, I. Kim, J. Pei, M. Wen et al., Doxorubicin-incorporated nanoparticles composed of poly (ethylene glycol)-grafted carboxymethyl chitosan and antitumor activity against glioma cells in vitro, Colloids and Surfaces B: Biointerfaces, vol.79, pp.149-155, 2010.

E. Jestin, M. Mougin-degraef, A. Faivre-chauvet, . Remaud-le, P. Saec et al., Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy, Q. J. Nucl. Med. Mol. Imaging, vol.51, pp.51-60, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00258368

H. Ji and Z. Lu, The role of protein kinase CK2 in glioblastoma development, Clin. Cancer Res, vol.19, pp.6335-6337, 2013.

W. Jiang, B. Y. Kim, J. T. Rutka, and W. C. Chan, Nanoparticle-mediated cellular response is size-dependent, Nature Nanotechnology, vol.3, pp.145-150, 2008.

L. Juillerat-jeanneret, The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?, Drug discovery today, vol.13, pp.1099-1106, 2008.

T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao et al., Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?, Eur. J. Pharm. Biopharm, vol.50, pp.147-160, 2000.

A. V. Kabanov, E. V. Batrakova, and D. W. Miller, Pluronic® block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier, Advanced Drug Delivery Reviews, vol.55, pp.151-164, 2003.

Y. Kaneda, Virosomes: evolution of the liposome as a targeted drug delivery system, Adv. Drug Deliv. Rev, vol.43, pp.197-205, 2000.

O. O. Kanu, A. Mehta, C. Di, N. Lin, K. Bortoff et al., Glioblastoma multiforme: a review of therapeutic targets, Expert Opin. Ther. Targets, vol.13, pp.701-718, 2009.

R. Karim, C. Palazzo, B. Evrard, and G. Piel, Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art, J. Control. Release, vol.227, pp.23-37, 2016.

L. Kelland, The resurgence of platinum-based cancer chemotherapy, Nat. Rev. Cancer, vol.7, pp.573-584, 2007.

E. M. Kemper, A. E. Van-zandbergen, C. Cleypool, H. A. Mos, W. Boogerd et al., Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein, Clin. Cancer Res, vol.9, pp.2849-2855, 2003.

X. Liu, K. A. Howard, M. Dong, M. O. Andersen, U. L. Rahbek et al., The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing, Biomaterials, vol.28, pp.1280-1288, 2007.

Y. Liu and W. Lu, Recent advances in brain tumor-targeted nano-drug delivery systems, Expert opinion on drug delivery, vol.9, pp.671-686, 2012.

G. Lolli, G. Cozza, M. Mazzorana, E. Tibaldi, L. Cesaro et al., Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight, Biochemistry, vol.51, pp.6097-6107, 2012.

J. A. Losman, W. G. Kaelin, and . Jr, What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer, Genes Dev, vol.27, pp.836-852, 2013.

D. N. Louis, H. Ohgaki, O. D. Wiestler, W. K. Cavenee, P. C. Burger et al., The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, vol.114, pp.97-109, 2007.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., , 2016.

, World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, pp.803-820

H. F. Lu, Y. J. Chie, M. S. Yang, C. S. Lee, J. J. Fu et al., Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax-and Bcl-2-triggered mitochondrial pathway, Int. J. Oncol, vol.36, pp.1477-1484, 2010.

W. Lu, J. Wan, Z. She, and X. Jiang, Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle, J. Control. Release, vol.118, pp.38-53, 2007.

W. Lu, Y. Zhang, Y. Z. Tan, K. L. Hu, X. G. Jiang et al., Cationic albuminconjugated pegylated nanoparticles as novel drug carrier for brain delivery, J. Control. Release, vol.107, pp.428-448, 2005.

G. Lukowski, R. Müller, B. Müller, and M. Dittgen, Acrylic acid copolymer nanoparticles for drug delivery: I. Characterization of the surface properties relevant for in vivo organ distribution, Int. J. Pharm, vol.84, pp.23-31, 1992.

I. Lynch, T. Cedervall, M. Lundqvist, C. Cabaleiro-lago, S. Linse et al., The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century, Adv. Colloid Interface Sci, vol.134, issue.135, pp.167-174, 2007.

A. Madhankumar, B. Slagle-webb, O. Mrowczynski, R. Payne, B. Zacharia et al., EXTH-32. Combination of Ras inhibitor and doxorubicin in liposomes enhances therapeutic efficacy in glioblastoma mouse model, Neuro Oncol, vol.18, pp.66-66, 2016.

A. B. Madhankumar, B. Slagle-webb, A. Mintz, J. M. Sheehan, and J. R. Connor, Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme, Mol. Cancer Ther, vol.5, pp.3162-3169, 2006.

F. Maher, S. J. Vannucci, and I. A. Simpson, Glucose transporter proteins in brain, FASEB J, vol.8, pp.1003-1011, 1994.

M. Matsuura, Y. Yamazaki, M. Sugiyama, M. Kondo, H. Ori et al., Polycation liposome-mediated gene transfer in vivo, Biochim. Biophys. Acta, vol.1612, pp.136-143, 2003.

N. Panté and M. Kann, Nuclear pore complex is able to transport macromolecules with diameters of? 39 nm, Mol. Biol. Cell, vol.13, pp.425-434, 2002.

P. Parajuli, N. Joshee, A. M. Rimando, S. Mittal, and A. K. Yadav, In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids, Planta Med, vol.75, pp.41-48, 2009.

W. M. Pardridge, Non-invasive drug delivery to the human brain using endogenous blood-brain barrier transport systems, Pharm. Sci. Technolo. Today, vol.2, pp.49-59, 1999.

W. M. Pardridge, Crossing the blood-brain barrier: are we getting it right?, Drug discovery today, vol.6, pp.1-2, 2001.

W. M. Pardridge, Drug and gene delivery to the brain: the vascular route, Neuron, vol.36, pp.555-558, 2002.

W. M. Pardridge, Drug transport across the blood-brain barrier, J. Cereb. Blood Flow Metab, vol.32, pp.1959-1972, 2012.

W. M. Pardridge, J. Eisenberg, and J. Yang, Human blood-brain barrier insulin receptor, J. Neurochem, vol.44, pp.1771-1778, 1985.

J. H. Park, S. Kwon, J. O. Nam, R. W. Park, H. Chung et al., Self-assembled nanoparticles based on glycol chitosan bearing 5beta-cholanic acid for RGD peptide delivery, J. Control. Release, vol.95, pp.579-588, 2004.

S. H. Park, S. G. Oh, J. Y. Mun, and S. S. Han, Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities, Colloids Surf B Biointerfaces, vol.48, pp.112-118, 2006.

D. Patel, S. Shukla, and S. Gupta, Apigenin and cancer chemoprevention: progress, potential and promise (review), Int. J. Oncol, vol.30, pp.233-245, 2007.

E. Pereverzeva, I. Treschalin, D. Bodyagin, O. Maksimenko, K. Langer et al., Influence of the formulation on the tolerance profile of nanoparticle-bound doxorubicin in healthy rats: focus on cardio-and testicular toxicity, Int. J. Pharm, vol.337, pp.346-356, 2007.

M. C. Perry, M. Demeule, A. Regina, R. Moumdjian, and R. Beliveau, Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts, Mol. Nutr. Food Res, vol.54, pp.1192-1201, 2010.

B. Petri, A. Bootz, A. Khalansky, T. Hekmatara, R. Muller et al., Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants, J. Control. Release, vol.117, pp.51-58, 2007.

Z. Pi, X. Chen, F. Li, Y. Li, Y. Chen et al., Therapeutic effect of paclitaxel liposomes delivered by ultrasound with microbubbles on nude mice bearing intracranial glioblastoma xenografts monitored by bioluminescence imaging, Ultrasonics Symposium (IUS), pp.1-4, 2016.

K. H. Plate, A. Scholz, and D. J. Dumont, Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited, Acta Neuropathol, vol.124, pp.763-775, 2012.

P. Ponka and C. N. Lok, The transferrin receptor: role in health and disease, Int. J. Biochem. Cell Biol, vol.31, pp.1111-1137, 1999.

M. D. Prados, S. J. Schold, H. A. Fine, K. Jaeckle, F. Hochberg et al., A randomized, double-blind, 2003.

E. Allard, D. Jarnet, A. Vessieres, S. Vinchon-petit, G. Jaouen et al., Local delivery of ferrociphenol lipid nanocapsules followed by external radiotherapy as a synergistic treatment against intracranial 9L glioma xenograft, Pharm. Res, vol.27, pp.56-64, 2010.

E. Allard, C. Passirani, and J. P. Benoit, Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, pp.2302-2318, 2009.

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, J. Control. Release, vol.130, pp.146-153, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00343557

E. Baeten, S. Vanslambrouck, C. Jérôme, P. Lecomte, and T. Junkers, Anionic flow polymerizations toward functional polyphosphoesters in microreactors: Polymerization and UV-modification, Eur. Polym. J, vol.80, pp.208-218, 2016.

M. A. Bellavance, M. B. Poirier, and D. Fortin, Uptake and intracellular release kinetics of liposome formulations in glioma cells, Int. J. Pharm, vol.395, pp.251-259, 2010.

A. Bernardi, E. Braganhol, E. Jager, F. Figueiro, M. I. Edelweiss et al., Indomethacin-loaded nanocapsules treatment reduces in vivo glioblastoma growth in a rat glioma model, Cancer Lett, vol.281, pp.53-63, 2009.

S. Bhattacharjee, DLS and zeta potential -What they are and what they are not?, J. Control. Release, vol.235, pp.337-351, 2016.

E. Blanco, H. Shen, and M. Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol, vol.33, pp.941-951, 2015.

E. Borenfreund, H. Babich, and N. Martin-alguacil, Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests, Toxicol. In Vitro, vol.2, pp.1-6, 1988.

S. Cajot, N. Lautram, C. Passirani, and C. Jerome, Design of reversibly core crosslinked micelles sensitive to reductive environment, J. Control. Release, vol.152, pp.30-36, 2011.

A. L. Capriotti, G. Caracciolo, C. Cavaliere, P. Foglia, D. Pozzi et al., Do plasma proteins distinguish between liposomes of varying charge density?, J. Proteomics, vol.75, pp.1924-1932, 2012.

G. Caracciolo, Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines, Nanomedicine, vol.11, pp.543-557, 2015.

B. Clement, B. Grignard, L. Koole, C. Jérôme, and P. Lecomte, Metal-free strategies for the synthesis of functional and well-defined polyphosphoesters, Macromolecules, vol.45, pp.4476-4486, 2012.

S. I. Jeon, J. H. Lee, J. D. Andrade, and P. G. De-gennes, Protein-surface interactions in the presence of polyethylene oxide, J. Colloid Interface Sci, vol.142, pp.149-158, 1991.

R. Karim, C. Palazzo, B. Evrard, and G. Piel, Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art, J. Control. Release, vol.227, pp.23-37, 2016.

R. Karim, C. Palazzo, J. Laloy, A. S. Delvigne, S. Vanslambrouck et al., Development and Evaluation of Injectable Nanosized Drug Delivery Systems for Apigenin, Int. J. Pharm, 2017.

R. Karim, S. Somani, M. Al-robaian, M. Mullin, R. Amor et al., Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E ?-tocotrienol, J. Control. Release, vol.246, pp.79-87, 2017.

A. Kroll, M. H. Pillukat, D. Hahn, and J. Schnekenburger, Current in vitro methods in nanoparticle risk assessment: limitations and challenges, Eur. J. Pharm. Biopharm, vol.72, pp.370-377, 2009.

F. Lacoeuille, F. Hindré, F. Moal, J. Roux, C. Passirani et al., In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel, Int. J. Pharm, vol.344, pp.143-149, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00258366

A. Laine, A. Clavreul, A. Rousseau, C. Tétaud, A. Vessieres et al., Inhibition of ectopic glioma tumor growth by a potent ferrocenyl drug loaded into stealth lipid nanocapsules, Nanomedicine, vol.10, pp.1667-1677, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01624361

A. L. Laine, J. Gravier, M. Henry, L. Sancey, J. Bejaud et al., Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring, J. Control. Release, vol.188, pp.1-8, 2014.

A. Lamprecht, Y. Bouligand, and J. P. Benoit, New lipid nanocapsules exhibit sustained release properties for amiodarone, J. Control. Release, vol.84, pp.59-68, 2002.

K. Lappalainen, I. Jaaskelainen, K. Syrjanen, A. Urtti, and S. Syrjanen, Comparison of cell proliferation and toxicity assays using two cationic liposomes, Pharm. Res, vol.11, pp.1127-1131, 1994.

J. H. Lee, H. Y. Zhou, S. Y. Cho, Y. S. Kim, Y. S. Lee et al., Antiinflammatory mechanisms of apigenin: inhibition of cyclooxygenase-2 expression, adhesion of monocytes to human umbilical vein endothelial cells, and expression of cellular adhesion molecules, Arch. Pharm. Res, vol.30, pp.1318-1327, 2007.

P. Lertsutthiwong, K. Noomun, N. Jongaroonngamsang, P. Rojsitthisak, and U. Nimmannit, Preparation of alginate nanocapsules containing turmeric oil, Carbohydr. Polym, vol.74, pp.209-214, 2008.

B. Li, D. H. Robinson, and D. F. Birt, Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development, J. Pharm. Sci, vol.86, pp.721-725, 1997.

F. Li, X. Zhao, H. Wang, R. Zhao, T. Ji et al., Multiple layer-by-layer lipid-polymer hybrid nanoparticles for improved FOLFIRINOX chemotherapy in pancreatic tumor models, Advanced Functional Materials, vol.25, pp.788-798, 2015.

L. Y. Lim, P. Y. Koh, S. Somani, M. Al-robaian, R. Karim et al., Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin, J. Pharm. Biomed. Anal, vol.117, pp.210-216, 2015.

D. Patel, S. Shukla, and S. Gupta, Apigenin and cancer chemoprevention: progress, potential and promise (review), Int. J. Oncol, vol.30, pp.233-245, 2007.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit et al., Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol, vol.2, pp.751-760, 2007.

J. M. Rabanel, P. Hildgen, and X. Banquy, Assessment of PEG on polymeric particles surface, a key step in drug carrier translation, J. Control. Release, vol.185, pp.71-87, 2014.

E. Roger, F. Lagarce, E. Garcion, and J. P. Benoit, Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis, J. Control. Release, vol.140, pp.174-181, 2009.

D. Romanova, A. Vachalkova, L. Cipak, Z. Ovesna, and P. Rauko, Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method, Neoplasma, vol.48, pp.104-107, 2001.

B. Ruozi, D. Belletti, A. Tombesi, G. Tosi, L. Bondioli et al., AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study, International journal of nanomedicine, vol.6, pp.557-563, 2011.

B. Saliou, O. Thomas, N. Lautram, A. Clavreul, J. Hureaux et al., Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide, Eur. J. Pharm. Sci, vol.50, pp.172-180, 2013.

J. Senior, J. C. Crawley, and G. Gregoriadis, Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection, Biochim. Biophys. Acta, vol.839, pp.1-8, 1985.

A. Sharma, U. S. Sharma, and R. M. Straubinger, Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia, Cancer Lett, vol.107, pp.265-272, 1996.

S. Shukla and S. Gupta, Apigenin: a promising molecule for cancer prevention, Pharm. Res, vol.27, pp.962-978, 2010.

S. C. Steiniger, J. Kreuter, A. S. Khalansky, I. N. Skidan, A. I. Bobruskin et al., Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles, Int. J. Cancer, vol.109, pp.759-767, 2004.

R. M. Straubinger, A. Sharma, M. Murray, and E. Mayhew, Novel Taxol formulations: Taxol-containing liposomes, J. Natl. Cancer Inst, pp.69-78, 1993.

O. Thomas and F. Lagarce, Lipid Nanocapsules: A Nanocarrier Suitable for Scale-Up Process, Journal of Drug Delivery Science and Technology, vol.23, pp.555-559, 2013.

H. H. Tonnesen, M. Masson, and T. Loftsson, Studies of curcumin and curcuminoids, 2002.

. Xxvii, Cyclodextrin complexation: solubility, chemical and photochemical stability, Int. J. Pharm, vol.244, pp.127-135

G. Tripodo, G. Pasut, A. Trapani, A. Mero, F. M. Lasorsa et al., Inulin-D-alpha-tocopherol succinate (INVITE) nanomicelles as a platform for effective intravenous administration of curcumin, Biomacromolecules, vol.16, pp.550-557, 2015.

M. Tungjai, W. Poompimon, C. Loetchutinat, S. Kothan, N. Dechsupa et al., Spectrophotometric characterization of behavior and the predominant species of flavonoids in physiological buffer: determination of solubility, lipophilicity and anticancer efficacy, Open Drug Deliv. J, vol.2, pp.10-19, 2008.

S. Vanslambrouck, Polyphosphate-based amphiphilic copolymers: synthesis and application to drug nanocarriers, 2015.

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. C. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, J. Biomed. Mater. Res, vol.78, pp.620-628, 2006.

L. Wan, C. Guo, Q. Yu, Y. Li, X. Wang et al., Quantitative determination of apigenin and its metabolism in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry, Journal of Chromatography B, vol.855, pp.286-289, 2007.

P. Wang, S. M. Henning, D. Heber, S. Watnasirichaikul, T. Rades et al., Effects of formulation variables on characteristics of poly (ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions, Int. J. Pharm, vol.5, pp.237-246, 2002.

X. Wei, J. Gao, C. Zhan, C. Xie, Z. Chai et al., Liposome-based glioma targeted drug delivery enabled by stable peptide ligands, J. Control. Release, vol.218, pp.13-21, 2015.

J. Wolfram, K. Suri, Y. Yang, J. Shen, C. Celia et al., Shrinkage of pegylated and non-pegylated liposomes in serum, Colloids Surf B Biointerfaces, vol.114, p.4, 2014.

X. Xu, L. Yu, and G. Chen, Determination of flavonoids in Portulaca oleracea L. by capillary electrophoresis with electrochemical detection, J. Pharm. Biomed. Anal, vol.41, pp.493-499, 2006.

Z. E. Yilmaz and C. Jerome, Polyphosphoesters: New Trends in Synthesis and Drug Delivery Applications, Macromol. Biosci, vol.16, pp.1745-1761, 2016.

Z. E. Yilmaz, S. Vanslambrouck, S. Cajot, J. Thiry, A. Debuigne et al., Core cross-linked micelles of polyphosphoester containing amphiphilic block copolymers as drug nanocarriers, RSC Adv, vol.6, pp.42081-42088, 2016.

J. Yuan, Z. Liu, Z. Hu, and G. Zou, Study on interaction between apigenin and human serum albumin by spectroscopy and molecular modeling, Journal of Photochemistry and Photobiology A: Chemistry, vol.191, pp.104-113, 2007.

A. Zanotto-filho, K. Coradini, E. Braganhol, R. Schroder, C. M. De-oliveira et al., Curcumin-loaded lipid-core nanocapsules as a strategy to improve pharmacological efficacy of curcumin in glioma treatment, Eur. J. Pharm. Biopharm, vol.83, pp.156-167, 2013.

J. Zhang, Y. Huang, D. Liu, Y. Gao, and S. Qian, Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement, Eur. J. Pharm. Sci, vol.48, pp.740-747, 2013.

J. Zhang, D. Liu, Y. Huang, Y. Gao, and S. Qian, Biopharmaceutics classification and intestinal absorption study of apigenin, Int. J. Pharm, vol.436, pp.311-317, 2012.

A. Aderem and D. M. Underhill, Mechanisms of phagocytosis in macrophages, Annu. Rev. Immunol, vol.17, pp.593-623, 1999.

E. Allard, C. Passirani, and J. P. Benoit, Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, pp.2302-2318, 2009.

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, J. Control. Release, vol.130, pp.146-153, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00343557

B. A. Avelar-freitas, V. G. Almeida, M. C. Pinto, F. A. Mourão, A. R. Massensini et al., Trypan blue exclusion assay by flow cytometry, Braz. J. Med. Biol. Res, vol.47, pp.307-3015, 2014.

J. Balzeau, M. Pinier, R. Berges, P. Saulnier, J. P. Benoit et al., The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells, Biomaterials, vol.34, pp.3381-3389, 2013.

L. M. Bareford and P. W. Swaan, Endocytic mechanisms for targeted drug delivery, Advanced drug delivery reviews, vol.59, pp.748-758, 2007.

A. Beduneau, P. Saulnier, and J. P. Benoit, Active targeting of brain tumors using nanocarriers, Biomaterials, vol.28, pp.4947-4967, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00198695

R. Berges, J. Balzeau, A. C. Peterson, and J. Eyer, A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis, Mol. Ther, vol.20, pp.1367-1377, 2012.

R. Berges, J. Balzeau, M. Takahashi, C. Prevost, and J. Eyer, Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulinbinding site on the light neurofilament subunit, PLoS One, vol.7, p.49436, 2012.

S. Cajot, N. Lautram, C. Passirani, C. Jerome, P. Canal et al., Design of reversibly core crosslinked micelles sensitive to reductive environment, J. Control. Release, vol.152, pp.1019-1038, 1998.

D. Carradori, P. Saulnier, V. Preat, A. Des-rieux, and J. Eyer, NFL-lipid nanocapsules for brain neural stem cell targeting in vitro and in vivo, J. Control. Release, vol.238, pp.253-262, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01392425

J. Chmielecki, J. Foo, G. R. Oxnard, K. Hutchinson, K. Ohashi et al., Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling, Sci. Transl. Med, vol.3, pp.90-59, 2011.

T. Chou, Drug combination studies and their synergy quantification using the Chou-Talalay method, Cancer Res, vol.70, pp.440-446, 2010.

T. C. Chou, Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies, Pharmacol. Rev, vol.58, pp.621-681, 2006.

S. D. Conner and S. L. Schmid, Regulated portals of entry into the cell, Nature, vol.422, pp.37-44, 2003.

F. Danhier, K. Messaoudi, L. Lemaire, J. P. Benoit, and F. Lagarce, Combined antiGalectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: in vivo evaluation, Int. J. Pharm, vol.481, pp.154-161, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392431

R. S. Dhanikula, A. Argaw, J. F. Bouchard, and P. Hildgen, Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability, Mol. Pharm, vol.5, pp.105-116, 2008.

J. Y. Fu, W. Zhang, D. R. Blatchford, L. Tetley, G. Mcconnell et al., Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration, J. Control. Release, vol.154, pp.20-26, 2011.

Y. Fu, N. An, K. Li, Y. Zheng, and A. Liang, Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs, J. Neurooncol, vol.107, pp.457-462, 2012.

G. Galati, O. Sabzevari, J. X. Wilson, and P. J. O'brien, Prooxidant activity and cellular effects of the phenoxyl radicals of dietary flavonoids and other polyphenolics, Toxicology, vol.177, pp.91-104, 2002.

L. Guo, L. Fan, Z. Pang, J. Ren, Y. Ren et al., TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes, J. Control. Release, vol.154, pp.93-102, 2011.

B. Gupta, T. S. Levchenko, and V. P. Torchilin, TAT peptide-modified liposomes provide enhanced gene delivery to intracranial human brain tumor xenografts in nude mice, Oncol. Res, vol.16, pp.351-359, 2007.

C. P. Haar, P. Hebbar, G. C. Wallace, A. Das, W. A. Vandergrift et al., Drug resistance in glioblastoma: a mini review, Neurochem. Res, vol.37, pp.1192-1200, 2012.

D. A. Hamstra, T. L. Chenevert, B. A. Moffat, T. D. Johnson, C. R. Meyer et al., Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.16759-16764, 2005.

H. Harashima, T. M. Huong, T. Ishida, Y. Manabe, H. Matsuo et al., Synergistic effect between size and cholesterol content in the enhanced hepatic uptake clearance of liposomes through complement activation in rats, Pharm. Res, vol.13, pp.1704-1709, 1996.

H. Harashima, K. Sakata, K. Funato, and H. Kiwada, Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes, Pharm. Res, vol.11, pp.402-406, 1994.

B. Heurtault, P. Saulnier, B. Pech, J. E. Proust, and J. P. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharm. Res, vol.19, pp.875-880, 2002.

N. T. Huynh, C. Passirani, E. Allard-vannier, L. Lemaire, J. Roux et al., Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma, Int. J. Pharm, vol.423, pp.55-62, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01865009

N. T. Huynh, C. Passirani, P. Saulnier, and J. P. Benoit, Lipid nanocapsules: a new platform for nanomedicine, Int. J. Pharm, vol.379, pp.201-209, 2009.

A. I. Ivanov, Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?, Methods Mol. Biol, vol.440, pp.15-33, 2008.

R. Karim, C. Palazzo, J. Laloy, A. S. Delvigne, S. Vanslambrouck et al., Development and Evaluation of Injectable Nanosized Drug Delivery Systems for Apigenin, Int. J. Pharm, 2017.

L. Kou, J. Sun, Y. Zhai, and Z. He, The endocytosis and intracellular fate of nanomedicines: Implication for rational design, Asian Journal of Pharmaceutical Sciences, vol.8, pp.1-10, 2013.

A. L. Laine, N. T. Huynh, A. Clavreul, J. Balzeau, J. Bejaud et al., Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules, Eur. J. Pharm. Biopharm, vol.81, pp.690-693, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01877954

T. H. Larsen, M. C. Branco, K. Rajagopal, J. P. Schneider, and E. M. Furst, Sequencedependent gelation kinetics of ?-hairpin peptide hydrogels, Macromolecules, vol.42, pp.8443-8450, 2009.

C. Lepinoux-chambaud, K. Barreau, and J. Eyer, The Neurofilament-Derived Peptide NFL-TBS.40-63 Targets Neural Stem Cells and Affects Their Properties, Stem cells translational medicine, vol.5, pp.901-913, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01412546

C. Lepinoux-chambaud and J. Eyer, The NFL-TBS.40-63 anti-glioblastoma peptide enters selectively in glioma cells by endocytosis, Int. J. Pharm, vol.454, pp.738-747, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01412546

G. Liu, H. Shen, J. Mao, L. Zhang, Z. Jiang et al., Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations, ACS Appl Mater Interfaces, vol.5, pp.6909-6914, 2013.

Y. Liu and W. Lu, Recent advances in brain tumor-targeted nano-drug delivery systems, Expert opinion on drug delivery, vol.9, pp.671-686, 2012.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., , 2016.

, World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, pp.803-820

Y. Mardor, R. Pfeffer, R. Spiegelmann, Y. Roth, S. E. Maier et al., Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging, J. Clin. Oncol, vol.21, pp.1094-1100, 2003.

E. Markoutsa, G. Pampalakis, A. Niarakis, I. A. Romero, B. Weksler et al., Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line, Eur. J. Pharm. Biopharm, vol.77, pp.265-274, 2011.

J. Mercer and A. Helenius, Virus entry by macropinocytosis, Nat. Cell Biol, vol.11, pp.510-520, 2009.

. Millipore, Monolayer integrity measurements and drug transport guidelines, 2016.

M. G. Netsky, B. August, and W. Fowler, The longevity of patients with glioblastoma multiforme, J. Neurosurg, vol.7, pp.261-269, 1950.

A. Paillard, F. Hindre, C. Vignes-colombeix, J. P. Benoit, and E. Garcion, The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability, Biomaterials, vol.31, pp.7542-7554, 2010.

Z. Pang, L. Feng, R. Hua, J. Chen, H. Gao et al., Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats, Mol. Pharm, vol.7, 1995.

W. M. Pardridge, Drug transport across the blood-brain barrier, J. Cereb. Blood Flow Metab, vol.32, pp.1959-1972, 2012.

S. P. Patil, P. D. Jain, J. S. Sancheti, P. J. Ghumatkar, R. Tambe et al., Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice, Neuropharmacology, vol.86, pp.192-202, 2014.

T. Patino, J. Soriano, L. Barrios, E. Ibanez, and C. Nogues, Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells, Sci. Rep, vol.5, p.11371, 2015.

D. M. Patterson, A. R. Padhani, and D. J. Collins, Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy, Nat. Clin. Pract. Oncol, vol.5, pp.220-233, 2008.

D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit et al., Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol, vol.2, pp.751-760, 2007.

B. Poller, H. Gutmann, S. Krahenbuhl, B. Weksler, I. Romero et al., The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies, J. Neurochem, vol.107, pp.1358-1368, 2008.

D. Prochazkova, I. Bousova, and N. Wilhelmova, Antioxidant and prooxidant properties of flavonoids, Fitoterapia, vol.82, pp.513-523, 2011.

M. Roger, A. Clavreul, N. T. Huynh, C. Passirani, P. Schiller et al., Ferrociphenol lipid nanocapsule delivery by mesenchymal stromal cells in brain tumor therapy, Int. J. Pharm, vol.423, pp.63-68, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01878529

D. Romanova, A. Vachalkova, L. Cipak, Z. Ovesna, and P. Rauko, Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method, Neoplasma, vol.48, pp.104-107, 2001.

G. Sahay, D. Y. Alakhova, and A. V. Kabanov, Endocytosis of nanomedicines, J. Control. Release, vol.145, pp.182-195, 2010.

R. Saito, J. R. Bringas, T. R. Mcknight, M. F. Wendland, C. Mamot et al., Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging, Cancer Res, vol.64, pp.2572-2579, 2004.

R. M. Straubinger, A. Sharma, M. Murray, and E. Mayhew, Novel Taxol formulations: Taxol-containing liposomes, J. Natl. Cancer Inst, pp.69-78, 1993.

D. Strother, D. Ashley, S. J. Kellie, A. Patel, D. Jones-wallace et al., Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study, J. Clin. Oncol, vol.19, pp.2696-2704, 2001.

T. A. Stump, B. N. Santee, L. P. Williams, R. A. Kunze, C. E. Heinze et al., The antiproliferative and apoptotic effects of apigenin on glioblastoma cells, J. Pharm. Pharmacol, 2017.

R. Stupp, M. E. Hegi, W. P. Mason, M. J. Van-den-bent, M. J. Taphoorn et al., European Organisation for, R., Treatment of Cancer Brain, T., Radiation Oncology, G., National Cancer Institute of Canada Clinical Trials, Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase, vol.10, pp.459-466, 2009.

A. A. Thomas, C. W. Brennan, L. M. Deangelis, and A. M. Omuro, Emerging therapies for glioblastoma, JAMA neurology, vol.71, pp.1437-1444, 2014.

O. Thomas and F. Lagarce, Lipid Nanocapsules: A Nanocarrier Suitable for Scale-Up Process, Journal of Drug Delivery Science and Technology, vol.23, pp.555-559, 2013.

R. G. Thorne and C. Nicholson, In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.5567-5572, 2006.

V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers, Nature reviews. Drug discovery, vol.4, pp.145-160, 2005.

V. P. Torchilin, R. Rammohan, V. Weissig, and T. S. Levchenko, TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors, P. Natl. Acad. Sci. USA, vol.98, pp.8786-8791, 2001.

A. Vonarbourg, C. Passirani, P. Saulnier, and J. P. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, pp.4356-4373, 2006.

X. Wei, J. Gao, C. Zhan, C. Xie, Z. Chai et al., Liposome-based glioma targeted drug delivery enabled by stable peptide ligands, J. Control. Release, vol.218, pp.13-21, 2015.

B. B. Weksler, E. A. Subileau, N. Perriere, P. Charneau, K. Holloway et al., Blood-brain barrier-specific properties of a human adult brain endothelial cell line, FASEB J, vol.19, pp.1872-1874, 2005.

S. Wohlfart, A. S. Khalansky, S. Gelperina, O. Maksimenko, C. Bernreuther et al., Efficient chemotherapy of rat glioblastoma using doxorubicinloaded PLGA nanoparticles with different stabilizers, PLoS One, vol.6, 2011.

Y. Xu, Y. Xin, Y. Diao, C. Lu, J. Fu et al., Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells, PLoS One, vol.6, p.29169, 2011.

Y. Yang, Z. Yan, D. Wei, J. Zhong, L. Liu et al., Tumor-penetrating peptide functionalization enhances the antiglioblastoma effect of doxorubicin liposomes, Nanotechnology, vol.24, p.405101, 2013.

X. Yu and J. Zheng, Polymorphic structures of Alzheimer's beta-amyloid globulomers, PLoS One, vol.6, 2011.

P. J. Yue, L. He, S. W. Qiu, Y. Li, Y. J. Liao et al., OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma, Mol. Cancer, vol.13, p.191, 2014.

C. Zhan, B. Gu, C. Xie, J. Li, Y. Liu et al., Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect, J. Control. Release, vol.143, pp.136-142, 2010.

L. Zhao, J. L. Wang, R. Liu, X. X. Li, J. F. Li et al., Neuroprotective, antiamyloidogenic and neurotrophic effects of apigenin in an Alzheimer's disease mouse model, Molecules, vol.18, pp.9949-9965, 2013.

L. Zhao, J. L. Wang, Y. R. Wang, and X. Z. Fa, Apigenin attenuates copper-mediated beta-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model, Brain Res, vol.1492, pp.33-45, 2013.

M. Zhou, A. M. Smith, A. K. Das, N. W. Hodson, R. F. Collins et al., Self-assembled peptide-based hydrogels as scaffolds for anchorage-dependent cells, Biomaterials, vol.30, pp.2523-2530, 2009.

E. Allard, C. Passirani, and J. P. Benoit, Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, pp.2302-2318, 2009.

E. Allard, C. Passirani, E. Garcion, P. Pigeon, A. Vessieres et al., Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, J. Control. Release, vol.130, pp.146-153, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00343557

J. Ambrose, Computerized transverse axial scanning (tomography). 2. Clinical application, Br. J. Radiol, vol.46, pp.1023-1047, 1973.

A. C. Anselmo and S. Mitragotri, Nanoparticles in the clinic, Bioengineering & Translational Medicine, vol.1, pp.10-29, 2016.

M. Bauman, G. Gillies, R. Raghavan, M. Brady, and C. Pedain, Physical characterization of neurocatheter performance in a brain phantom gelatin with nanoscale porosity: steady-state and oscillatory flows, Nanotechnology, vol.15, p.92, 2003.

M. A. Bellavance, M. B. Poirier, and D. Fortin, Uptake and intracellular release kinetics of liposome formulations in glioma cells, Int. J. Pharm, vol.395, pp.251-259, 2010.

A. H. Bennett, Case of Cerebral Tumour, Med. Chir. Trans, vol.68, pp.243-275, 1885.

E. Blanco, H. Shen, and M. Ferrari, Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nat. Biotechnol, vol.33, pp.941-951, 2015.

A. L. Capriotti, G. Caracciolo, C. Cavaliere, P. Foglia, D. Pozzi et al., Do plasma proteins distinguish between liposomes of varying charge density?, J. Proteomics, vol.75, pp.1924-1932, 2012.

G. Caracciolo, Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines, Nanomedicine, vol.11, pp.543-557, 2015.

L. A. Carver and J. E. Schnitzer, Caveolae: mining little caves for new cancer targets, Nat. Rev. Cancer, vol.3, pp.571-581, 2003.

T. Chang, J. A. Olson, R. T. Proffitt, and J. P. Adler-moore, Differences in tissue drug concentrations following intravenous versus intraperitoneal treatment with amphotericin B deoxycholate or liposomal amphotericin B, Med. Mycol, vol.48, pp.430-435, 2010.

M. Y. Chen, R. R. Lonser, P. F. Morrison, L. S. Governale, and E. H. Oldfield, Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time, J. Neurosurg, vol.90, pp.315-320, 1999.

X. J. Chen, M. Y. Wu, D. H. Li, and J. You, Apigenin inhibits glioma cell growth through promoting microRNA-16 and suppression of BCL-2 and nuclear factorkappaB/MMP9, Mol Med Rep, vol.14, pp.2352-2358, 2016.

A. Clavreul, A. Montagu, A. L. Laine, C. Tetaud, N. Lautram et al., Targeting and treatment of glioblastomas with human mesenchymal stem cells carrying ferrociphenol lipid nanocapsules, International journal of nanomedicine, vol.10, pp.1259-1271, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01392451

F. Danhier, O. Feron, and V. Preat, To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery, J. Control. Release, vol.148, pp.135-146, 2010.

A. Das, N. L. Banik, and S. K. Ray, Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes, Cancer, vol.116, pp.164-176, 2010.

S. Das, J. Das, A. Samadder, A. Paul, and A. R. Khuda-bukhsh, Strategic formulation of apigenin-loaded PLGA nanoparticles for intracellular trafficking, DNA targeting and improved therapeutic effects in skin melanoma in vitro, Toxicol. Lett, vol.223, pp.124-138, 2013.

L. M. Deangelis and I. K. Mellinghoff, Virchow 2011 or How to ID(H) Human Glioblastoma, J. Clin. Oncol, vol.29, pp.4473-4474, 2011.

J. W. Degen, S. Walbridge, A. O. Vortmeyer, E. H. Oldfield, and R. R. Lonser, Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats, J. Neurosurg, vol.99, pp.893-898, 2003.

B. Ding, H. Chen, C. Wang, Y. Zhai, and G. Zhai, Preparation and in vitro evaluation of apigenin loaded lipid nanocapsules, Journal of nanoscience and nanotechnology, vol.13, pp.6546-6552, 2013.

D. A. Eavarone, X. Yu, and R. V. Bellamkonda, Targeted drug delivery to C6 glioma by transferrin-coupled liposomes, J. Biomed. Mater. Res, vol.51, pp.10-14, 2000.

C. Engelmann, E. Blot, Y. Panis, S. Bauer, V. Trochon et al., Apigenin-strong cytostatic and anti-angiogenic action in vitro contrasted by lack of efficacy in vivo, Phytomedicine, vol.9, pp.489-495, 2002.

M. Faust and M. Montenarh, Subcellular localization of protein kinase CK2. A key to its function?, Cell Tissue Res, vol.301, pp.329-340, 2000.

G. Favaro, C. Clementi, A. Romani, and V. Vickackaite, Acidichromism and ionochromism of luteolin and apigenin, the main components of the naturally occurring yellow weld: a spectrophotometric and fluorimetric study, J. Fluoresc, vol.17, pp.707-714, 2007.

X. Feng, Q. Zhou, C. Liu, and M. Tao, Drug screening study using glioma stemlike cells, Mol. Med. Report, vol.6, pp.1117-1120, 2012.

V. J. Fiorina, R. J. Dubois, and S. Brynes, Ferrocenyl polyamines as agents for the chemoimmunotherapy of cancer, J. Med. Chem, vol.21, pp.393-395, 1978.

E. Garcia-garcia, K. Andrieux, S. Gil, and P. Couvreur, Colloidal carriers and bloodbrain barrier (BBB) translocation: a way to deliver drugs to the brain?, Int. J. Pharm, vol.298, pp.274-292, 2005.

E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-pouessel et al., A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Mol. Cancer Ther, vol.5, pp.1710-1722, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00129865

G. Gu, X. Gao, Q. Hu, T. Kang, Z. Liu et al., The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells, Biomaterials, vol.34, pp.5138-5148, 2013.

G. Gu, H. Xia, Q. Hu, Z. Liu, M. Jiang et al., PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy, Biomaterials, vol.34, pp.196-208, 2013.

J. Guo, X. Gao, L. Su, H. Xia, G. Gu et al., Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery, Biomaterials, vol.32, pp.8010-8020, 2011.
DOI : 10.1016/j.biomaterials.2011.07.004

C. Gzell, M. Back, H. Wheeler, D. Bailey, and M. Foote, Radiotherapy in Glioblastoma: the Past, the Present and the Future, Clin. Oncol. (R. Coll. Radiol.), vol.29, pp.15-25, 2017.

L. Harivardhan-reddy, R. K. Sharma, K. Chuttani, A. K. Mishra, and R. S. Murthy, Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton's lymphoma tumor bearing mice, J. Control. Release, vol.105, pp.185-198, 2005.

G. Jaouen, A. Vessieres, and S. Top, Ferrocifen type anti cancer drugs, Chem. Soc. Rev, vol.44, pp.8802-8817, 2015.
DOI : 10.1039/c5cs00486a
URL : https://hal.archives-ouvertes.fr/hal-01221048

M. Khan, F. Yi, A. Rasul, T. Li, N. Wang et al., Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction, IUBMB life, vol.64, pp.783-794, 2012.
DOI : 10.1002/iub.1068
URL : https://iubmb.onlinelibrary.wiley.com/doi/pdf/10.1002/iub.1068

R. A. Kroll, M. A. Pagel, L. L. Muldoon, S. Roman-goldstein, and E. A. Neuwelt, Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor, Neurosurgery, vol.38, pp.746-752, 1996.

A. L. Laine, N. T. Huynh, A. Clavreul, J. Balzeau, J. Bejaud et al., Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules, Eur. J. Pharm. Biopharm, vol.81, pp.690-693, 2012.
DOI : 10.1016/j.ejpb.2012.04.012
URL : https://hal.archives-ouvertes.fr/hal-01877954

A. Lamprecht and J. P. Benoit, Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition, J. Control. Release, vol.112, pp.208-213, 2006.
DOI : 10.1016/j.jconrel.2006.02.014

A. Lamprecht, Y. Bouligand, and J. P. Benoit, New lipid nanocapsules exhibit sustained release properties for amiodarone, J. Control. Release, vol.84, pp.59-68, 2002.

P. C. Lauterbur, Image formation by induced local interactions. Examples employing nuclear magnetic resonance, Clin. Orthop. Relat. Res, pp.3-6, 1973.

B. Li, D. H. Robinson, and D. F. Birt, Evaluation of properties of apigenin and [G-3H]apigenin and analytic method development, J. Pharm. Sci, vol.86, pp.721-725, 1997.

T. Lian and R. J. Ho, Trends and developments in liposome drug delivery systems, J. Pharm. Sci, vol.90, pp.667-680, 2001.

Y. Liu and W. Lu, Recent advances in brain tumor-targeted nano-drug delivery systems, Expert opinion on drug delivery, vol.9, pp.671-686, 2012.

D. N. Louis, A. Perry, G. Reifenberger, A. Von-deimling, D. Figarella-branger et al., , 2016.

, World Health Organization Classification of Tumors of the Central Nervous System: a summary, Acta Neuropathol, vol.131, pp.803-820

G. Lukas, S. D. Brindle, and P. Greengard, The route of absorption of intraperitoneally administered compounds, J. Pharmacol. Exp. Ther, vol.178, pp.562-564, 1971.

M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall et al., Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc. Natl. Acad. Sci. U. S. A, vol.105, pp.14265-14270, 2008.

L. Lv, Y. Jiang, X. Liu, B. Wang, W. Lv et al., Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles, Mol. Pharm, vol.13, pp.3506-3517, 2016.

L. K. Medina-kauwe, Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?, Advanced drug delivery reviews, vol.59, pp.798-809, 2007.

Y. Miura, T. Takenaka, K. Toh, S. Wu, H. Nishihara et al., Cyclic RGDlinked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier, ACS Nano, vol.7, pp.8583-8592, 2013.

N. Muhammad and Z. Guo, Metal-based anticancer chemotherapeutic agents, Curr. Opin. Chem. Biol, vol.19, pp.144-153, 2014.

A. E. Nel, L. Madler, D. Velegol, T. Xia, E. M. Hoek et al., Understanding biophysicochemical interactions at the nano-bio interface, Nat. Mater, vol.8, pp.543-557, 2009.

A. Nguyen, A. Vessières, E. A. Hillard, S. Top, P. Pigeon et al., Ferrocifens and ferrocifenols as new potential weapons against breast cancer, CHIMIA International Journal for Chemistry, vol.61, pp.716-724, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01230400

S. Palchetti, V. Colapicchioni, L. Digiacomo, G. Caracciolo, D. Pozzi et al., The protein corona of circulating PEGylated liposomes, Biochim. Biophys. Acta, vol.1858, pp.189-196, 2016.

Z. E. Papay, Z. Sebestyen, K. Ludanyi, N. Kallai, E. Balogh et al., Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin, J. Pharm. Biomed. Anal, vol.117, pp.210-216, 2016.

P. Parajuli, N. Joshee, A. M. Rimando, S. Mittal, and A. K. Yadav, In vitro antitumor mechanisms of various Scutellaria extracts and constituent flavonoids, Planta Med, vol.75, pp.41-48, 2009.

D. M. Patterson, A. R. Padhani, and D. J. Collins, Technology insight: water diffusion MRI--a potential new biomarker of response to cancer therapy, Nat. Clin. Pract. Oncol, vol.5, pp.220-233, 2008.

B. Peres, R. Nasr, M. Zarioh, F. Lecerf-schmidt, A. Di-pietro et al., Ferrocene-embedded flavonoids targeting the Achilles heel of multidrug-resistant cancer cells through collateral sensitivity, Eur. J. Med. Chem, vol.130, pp.346-353, 2017.

I. Romero-canelón, M. Mos, and P. J. Sadler, Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation, J. Med. Chem, vol.58, pp.7874-7880, 2015.

J. G. Roth and A. R. Elvidge, Glioblastoma multiforme: a clinical survey, J. Neurosurg, vol.17, pp.736-750, 1960.

G. Sahay, D. Y. Alakhova, and A. V. Kabanov, Endocytosis of nanomedicines, J. Control. Release, vol.145, pp.182-195, 2010.

A. Salazar-ramiro, D. Ramírez-ortega, V. Pérez-de-la-cruz, N. Y. Hérnandez-pedro, D. F. González-esquivel et al., Role of Redox Status in Development of Glioblastoma, Front. Immunol, vol.7, p.156, 2016.

B. L. Santos, M. N. Oliveira, P. L. Coelho, B. P. Pitanga, A. B. Da-silva et al., Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression, Chem. Biol. Interact, vol.242, pp.123-138, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01541425

T. Siegal, A. Horowitz, and A. Gabizon, Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy, J. Neurosurg, vol.83, pp.1029-1037, 1995.

I. Singh, R. Swami, D. Pooja, M. K. Jeengar, W. Khan et al., Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting, J. Drug Target, vol.24, pp.212-223, 2016.

E. A. Spiegel, H. T. Wycis, M. Marks, and A. J. Lee, Stereotaxic Apparatus for Operations on the Human Brain, Science, vol.106, pp.349-350, 1947.

T. A. Stump, B. N. Santee, L. P. Williams, R. A. Kunze, C. E. Heinze et al., The antiproliferative and apoptotic effects of apigenin on glioblastoma cells, J. Pharm. Pharmacol, 2017.

R. Stupp, W. P. Mason, M. J. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N. Engl. J. Med, vol.352, pp.987-996, 2005.

R. G. Thorne and C. Nicholson, In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space, Proc. Natl. Acad. Sci. U. S. A, vol.103, pp.5567-5572, 2006.

V. P. Torchilin, Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery, Biopolymers, vol.90, pp.604-610, 2008.

P. V. Turner, T. Brabb, C. Pekow, and M. A. Vasbinder, Administration of Substances to Laboratory Animals: Routes of Administration and Factors to Consider, Journal of the American Association for Laboratory Animal Science, vol.50, pp.600-613, 2011.

S. Vanslambrouck, Polyphosphate-based amphiphilic copolymers: synthesis and application to drug nanocarriers, 2015.

Y. Wang, P. Pigeon, S. Top, M. J. Mcglinchey, and G. Jaouen, Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides, Angew. Chem. Int. Ed. Engl, vol.54, pp.10230-10233, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01230371

L. Wasungu and D. Hoekstra, Cationic lipids, lipoplexes and intracellular delivery of genes, J. Control. Release, vol.116, pp.255-264, 2006.

A. Wieczorek, A. Blauz, A. Zal, H. J. Arabshahi, J. Reynisson et al., Ferrocenyl Paclitaxel and Docetaxel Derivatives: Impact of an Organometallic Moiety on the Mode of Action of Taxanes, Chemistry (Easton), vol.22, pp.11413-11421, 2016.

S. Wohlfart, A. S. Khalansky, S. Gelperina, O. Maksimenko, C. Bernreuther et al., Efficient Chemotherapy of Rat Glioblastoma Using DoxorubicinLoaded PLGA Nanoparticles with Different Stabilizers, PLoS One, vol.6, 2011.

X. Ying, H. Wen, W. L. Lu, J. Du, J. Guo et al., Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, J. Control. Release, vol.141, pp.183-192, 2010.

P. J. Yue, L. He, S. W. Qiu, Y. Li, Y. J. Liao et al., OX26/CTX-conjugated PEGylated liposome as a dual-targeting gene delivery system for brain glioma, Mol. Cancer, vol.13, p.191, 2014.

X. D. Zhang, H. Y. Wu, D. Wu, Y. Y. Wang, J. H. Chang et al., Toxicologic effects of gold nanoparticles in vivo by different administration routes, International journal of nanomedicine, vol.5, pp.771-781, 2010.

Y. Zheng, B. C. Mcfarland, D. Drygin, H. Yu, S. L. Bellis et al., Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma, Clin. Cancer Res, vol.19, pp.6484-6494, 2013.